House, Senate Panels Agree On Compounder Oversight Bill
Legislation that would give the U.S. Food and Drug Administration greater authority to regulate companies that compound sterile drugs has won bipartisan support as U.S. House and Senate committees overseeing health...To view the full article, register now.
Already a subscriber? Click here to view full article